Loading...
•
Dec 31, 2025
PROCEPT BioRobotics Q4 2025 Earnings Report
PROCEPT BioRobotics Q4 2025 Earnings Report
Key Takeaways
PROCEPT BioRobotics reported Q4 2025 revenue of $76.4 million, a 12% increase year-over-year, driven by record procedure volumes and system placements. Despite strong operational metrics, the company missed revenue expectations due to a strategic decision to reduce field inventory and eliminate end-of-quarter incentives, resulting in a wider net loss of $29.8 million.
Achieved record quarterly procedure volume of approximately 12,200, representing 69% year-over-year growth.
Sold 65 new systems in Q4, marking the strongest capital quarter in the company's history.
Implemented a disciplined pricing strategy that increased handpiece average selling price by 5% sequentially to $3,340.
Reset 2026 revenue guidance to $390-$410 million to align handpiece sales more closely with actual procedure volumes.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The company reset its 2026 revenue guidance to reflect a more disciplined commercial strategy and alignment of handpiece sales with procedure volumes.
Positive Outlook
- Full year 2026 revenue expected to grow 27% to 33% to $390-$410 million.
- U.S. procedure growth projected at 39% to 48% for 2026.
- Expected improvement in gross margin to approximately 65%.
- Handpiece pricing expected to increase to $3,500 per unit.
- Adjusted EBITDA loss expected to narrow to $17-$30 million.
Challenges Ahead
- Resetting 2026 guidance lower than previous expectations.
- Short-term disruption expected from sales force realignment.
- Decision to align handpiece sales with procedures reduces projected handpiece revenue.
- Operating expenses expected to remain high at approximately $350 million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...